Skip to main content
Veterinary Medicines

Cephacare flavour 250 mg tablets for dogs

Authorised
  • Cefalexin monohydrate

Product identification

Medicine name:
Cephacare flavour 250 mg tablets for dogs
CEPHACARE F 250 MG COMPRIMES POUR CHIENS
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    262.95
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • Cephacare flavour 250 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 20 tablets.
  • Cephacare flavour 250 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 100 tablets.
  • Cephacare flavour 250 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 250 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • Produlab Pharma B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5441373 9/2008
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0454/002
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 6/04/2025
Download
French (PDF)
Published on: 17/04/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 17/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."